This site is intended for Healthcare Professionals only.

Search results for: PATIENT SAFETY

Gilead’s Remdesivir gets conditional EU clearance

The European Commission said on Friday (July 3) it had given conditional approval for the use of antiviral remdesivir in severe Covid-19 patients following...

Defect alert for Depo-Provera 150mg/ml injection

The Medicines and Health products Regulatory Agency (MHRA) has issued a class four medicines defect information notice for Depo-Provera 150mg/ml injection. The marketing authorisation holder,...

Covid-19 boosted parents willingness to vaccinate children: GSK Survey

In the wake of Covid-19 pandemic, parents of the young children believe that vaccinations are more essential to contain infectious diseases, a latest study...

Novartis halts malaria drug trial against Covid-19

Swiss drugmaker Novartis is halting its trial of malaria drug hydroxychloroquine (HCQ) against Covid-19 after struggling to find participants, it said on Friday (June...

MHRA suspends hydroxychloroquine trial recruitment

The Medicines and Healthcare products Regulatory Agency (MHRA) has instructed UK clinical trialists using hydroxychloroquine to treat or prevent coronavirus to suspend recruitment of...

Risk assessment survey for pharmacists launched

The Royal Pharmaceutical Society (RPS) and the Black Pharmacists Association (UKBPA) have launched a survey on Friday (June 12) to ensure the safety of...